Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2984

Agios’ Pyrukynd succeeds in key trial of rare red blood cell disorder in kids

$
0
0
Agios' blood disease treatment Pyrukynd passed a Phase 3 study in PK deficiency in children who do not regularly receive blood transfusions. The readout arrives after Pyrukynd last year failed to meet ...

Viewing all articles
Browse latest Browse all 2984

Trending Articles